As published by Jurist
Professor Daryl Lim, Director of the Center for Intellectual Property, Information Technology & Privacy Law, discussed the implications of the recent investigations into pharmaceutical manufacturers’ pricing and its implications for antitrust law and the generic pharmaceutical industry in his recent article “Antitrust and the Mylan Conspiracy” in Jurist, the web-based legal news and real-time legal research service website.
